Updated Annual & Quarterly Earnings Report Filing for Ibio Inc IBIO-A. >Earnings Surprises. Earnings Estimates are available only for US equities. iBio also recorded a net loss of $7.5 million last quarter, compared to a loss of $4.5 million during the same time in 2019. Stay up to date with lastest Earnings Announcements for iBio, Inc. from Zacks Investment Research Q1、Q2、Q3、Q4 represent three-month periodic financial reports. 2021 was $-24.41 Mil. IBIO stocks went up by 9.56% for the week, with a monthly jump of 12.03% and a quarterly performance of -26.24%, while its annual performance rate touched -1.32%. There are also historical financial reports for you to reference. Earnings estimates and surprises for Ibio Inc (IBIO) are an important tool used to evaluate the company's overall strength and value of the stock. At the time of this writing, the total market value of the company is set at 321.90M, as it employees total of 43 workers. Listen to the conference call and remind yourself by… Read more. It appears that the average earnings per share estimate for the current quarter (ending in Mar 2021) is $0. iBio, Inc.(), a biotech innovator and biologics contract manufacturing organization, today announced its financial results for the fiscal quarter ended March 31, 2021Fiscal Third Quarter and Recent Corporate Developments: Fiscal year to-date, iBio increased staffing by approximately 21% to 57 employees. IBIO Earnings. In the press release, iBio said that it plans on reporting its fiscal first quarter of 2021 financial results after market close on Monday, November 16, 2020. iBio, Inc. is a biotechnology company, which engages in the development and manufacture of biotherapeutics. IBIO stocks went down by -13.29% for the week, with a monthly drop of -23.03% and a quarterly performance of 14.17%, while its annual performance rate touched 46.56%. There … iBio Inc (IBIO) released its third quarter results on Monday, May 17, 2021. Other Ticker Details IBIO Company Name iBio Inc Earnings Call Date 16-02-2021 Time (ET) 16:30 Fiscal Quarter Q2 Fiscal Year 2021 Live Webcast URL IBIO’s Market Performance. Ibio (IBIO) is seeing shares of IBIO stock soar higher on Wednesday following news of a contract for the biotech company. This table is designed to uncover Earnings Surprises — times when a stock's earnings either out-perform or under-perform the analysts' expectations. Image Credit iBio . We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. The biotechnology company reported ($0.04) EPS for the quarter, hitting the Thomson Reuters’ consensus estimate of ($0.04). Earnings Trend: IBIO is unprofitable, and losses have increased over the past 5 years at a rate of 26.2% per year. IBio eps - earnings per share from 2009 to 2021. The volatility ratio for the week stands at 8.33% while the volatility levels for the past 30 days are set at 10.57% for iBio Inc.. It appears that the average earnings per share estimate for the current quarter (ending in Mar 2021) is $0. November 16, 2020 - 4:05 pm. IBIO Climbs On Coming Financial Results & Update. When it comes to the year-to-date metrics, the iBio Inc. (IBIO) recorded performance in the market was 40.00%, having the revenues showcasing -39.26% on a quarterly basis in comparison with the same period year before. iBio Inc. is expected to release its quarterly report on 10/19/2021 and quarterly earnings per share for the current quarter are estimated at $0 with sales reaching $800k over the same period.The EPS is expected to grow by 35.40% this year, but quarterly earnings … The volatility ratio for the week stands at 8.47% while the volatility levels for the past 30 days are set at 7.32% for iBio Inc.. The first table on the Estimates page compares Actual vs. What is the current enterprise value of iBio Inc? iBio Inc. analyst estimates, including IBIO earnings per share estimates and analyst recommendations. The company reported net earnings of $-0.04 per share for the third quarter ending March 31, 2021. iBio News: Why IBIO Stock Is Soaring 16% Today. The total revenue of IBIO for the last quarter is 765.00k, and it's 8.51% higher compared to the previous quarter. iBio Must-See Earnings Estimates Stock market Insights & financial analysis 12:35pm, Tuesday, 16'th Feb 2021. iBio announce their quarterly, annual earnings. Q1、Q2、Q3、Q4 represent three-month periodic financial reports. The company, currently valued at $335.76M, closed the last trade at $1.59 per share which meant it lost -$0.04 on the day or -2.45% during that session. Evaluating demand and supply activities around IBIO's earnings. NEW YORK, NY / ACCESSWIRE / February 16, 2021 / iBio, Inc. (AMEX:IBIO) will be discussing their earnings results in their 2021 Second Quarter Earnings … Conference Call,Earnings NEW YORK, NY / ACCESSWIRE / February 16, 2021 / iBio, Inc. (AMEX:IBIO) will be discussing their earnings results in their 2021 Second Quarter Earnings call to be held on February 16, 2021 at 4:30 PM Eastern Time. iBio Q1 net loss widens as expenses soar year-over-year; shares fall 6%. iBio, Inc. (NYSE: IBIO) Q3 2021 Results Earnings Conference Call May 17, 2021 8:00 AM ET. iBio, Inc. (IBIO) estimates and forecasts. Get the hottest stocks to trade every day before the market opens 100% free. To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. Conference Call,Earnings NEW YORK, NY / ACCESSWIRE / May 17, 2021 / iBio, Inc. (NYSE:IBIO) will be discussing their earnings results in their 2021 Third Quarter Earnings call to be held on May 17, 2021 at 8:00 AM Eastern Time. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants. BRYAN, Tx., Feb. 16, 2021 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) ("iBio" or the "Company"), a biotech innovator and biologics contract manufacturing organization, today announced its financial results for the fiscal quarter ended December 31, 2020. iBio, Inc. has a license agreement with Planet Biotechnology, Inc. to develop therapeutics for infectious diseases; … iBio Inc. Quarterly stock financials by MarketWatch. Company. Today, the average trading volume of IBIO was 14.00M shares. A number of hedge funds have recently modified their holdings of IBIO. The company's current Enterprise Value is estimated at 355.23 Million. IBio Stock Analysis Notes About 14.0% of the company shares are owned by institutional investors. A recently released report on iBio’s fiscal fourth-quarter results provides important updates on the company’s progress with IBIO-201. 3 We do not currently have option data for IBIO During the 10/19/2021 quarter of the year, iBio Inc. recorded a total of 0.77 million in revenue. NEW YORK, NY / ACCESSWIRE / February 16, 2021 / iBio, Inc. (AMEX:IBIO) will be discussing their earnings results in their 2021 Second Quarter Earnings … The book value of IBio was currently reported as 0.51. IBIO stocks went up by 4.67% for the week, with a monthly jump of 6.80% and a quarterly performance of -10.80%, while its annual performance rate touched 0.64%. The following information was filed by Ibio, Inc. (IBIO) on Tuesday, October 13, 2020 as an 8K 2.02 statement, which is an earnings press release pertaining to … The iBio Technology platform is a proprietary, transformative technology for the production of biologics including monoclonal antibodies, other therapeutic proteins and vaccines. Having accumulated decades of collective experience across a variety of fields, our leadership team is the source of our success. In the same quarter last year, iBio's earnings per share (EPS) was -$0.06. SAP stock fell 23%, but that figure understates the case. iBio Inc. is due to release its next quarterly earnings in July. 05/17 10:08. Note that the Earnings Whisper ® number is based on analysts' expectations and EarningsWhispers' research. The biotechnology company reported ($0.04) earnings per share (EPS) for the quarter, meeting the Zacks’ consensus estimate of ($0.04). 2 Earnings Whispers' estimate. Total iBio earnings for the quarter were -$7.73 million. BRYAN, Texas, Nov. 16, 2020 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a biotech innovator and biologics contract manufacturing organization, today announced its financial results for the fiscal quarter ended September 30, 2020. “We made tremendous strides during the first few months of Fiscal Year … For the fiscal quarter ended March 31, 2021, iBio reported revenues of approximately $0.8 million, an increase of $0.7 million from $0.1 million in the fiscal quarter ended March 31, 2020. Check out IBIO latest quarterly and annual financial reports. Niu Technologies has generated $0.36 earnings per share over the last year and currently has a price-to-ear. Visitor information is not used to determine the Earnings Whisper ® number. ... Quarterly Change in Shares Ownership in Company; 5/24/2021: Principal Financial Group Inc. ... data and objective market analysis. iBio, Inc.(), a biotech innovator and biologics contract manufacturing organization, today announced its financial results for the fiscal quarter ended March 31, 2021Fiscal Third Quarter and Recent Corporate Developments: Fiscal year to-date, iBio increased staffing by approximately 21% to 57 employees. You can analyze IBIO recent business situations by check its cash flow statements, balance sheets, income statements and other tables. iBio had a negative return on equity of 55.71% and a negative net margin of 1,005.62%. In comparison, last year the company earned revenue of $527K and had a GAAP net loss of $4.22 million. IBIO. The biotechnology company reported ($0.04) earnings per share for the quarter, meeting the consensus estimate of ($0.04). The latest earnings per stock, revenues and financial reports for Ibio Inc (IBIO). Do NOT follow this link! iBio Inc. (AMEX:IBIO) has a beta value of -6.22 and has seen 4.43 million shares traded in the last trading session. This figure implies that they witnessed a quarterly year/year change in their earnings with 87.45% coming in sequential stages and their sales for the 10/19/2021 quarter increasing by 7.84%. NEW YORK, NY / ACCESSWIRE / February 16, 2021 / iBio, Inc. (AMEX:IBIO) will be discussing their earnings results in their 2021 Second Quarter Earnings call to be held on February 16, 2021 at 4:30 PM Eastern Time. Ibio Stock May Be A Long Play For Risk-Tolerant Investors.

Locusts North Carolina 1700s, Stillfront Investor Relations, Punterslounge Prediction, Identify International Airport, Muscle Shoals Restaurant, Magoosh Gmat Testimonials, Epic Games Rocket League 2fa, Entry Level Aml Jobs London,